BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Sees Significant Growth in Short Interest

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the recipient of a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 3,600 shares, a growth of 125.0% from the February 13th total of 1,600 shares. Based on an average daily volume of 90,200 shares, the short-interest ratio is currently 0.0 days.

BriaCell Therapeutics Stock Down 6.7 %

NASDAQ:BCTXW opened at $0.09 on Friday. The stock’s fifty day moving average price is $0.14 and its two-hundred day moving average price is $0.25. BriaCell Therapeutics has a 52-week low of $0.07 and a 52-week high of $1.70.

BriaCell Therapeutics Company Profile

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.